Three key points about biofilm models:
1) There are several in vitro and in vivo models for studying multispecies bacterial biofilms, each with strengths and weaknesses.
2) 3D printed biofilm models provide a robust and reproducible model for testing antimicrobials both in vitro and in vivo with less variability than other models.
3) When testing new antimicrobial therapies, researchers should use more than one biofilm model to validate results given the pitfalls of individual models.
Monoclonal antibodies are antibodies that are produced by a single clone of cells and have identical binding sites. This document discusses the production of monoclonal antibodies through hybridoma technology, where antibody-producing B cells are fused with myeloma cells. It also summarizes the various applications of monoclonal antibodies in diagnostics, imaging, therapy, and purification. Monoclonal antibodies can be specifically targeted to antigens on cancer cells, delivering toxic drugs directly to tumors while sparing normal cells. Their high specificity makes them useful research and medical tools.
Sensing metabolites for the monitoring of tissue engineered construct cellula...Antoine DEGOIX
This document describes a study that aimed to develop correlations between metabolic rates (oxygen uptake, glucose consumption, lactate production) and cellularity of tissue-engineered constructs comprised of rat mesenchymal stem cells seeded on scaffolds and cultured in a perfusion bioreactor. Metabolite measurements were taken intermittently using a fiber-optic probe or assays, and correlated with cellularity data obtained destructively via DNA quantification. The resulting high R2 value correlations provide proof-of-concept that metabolic data can determine scaffold cellularity non-destructively and in real-time.
A Systems Approachto Personalized MedicineLarry Smarr
A Systems Approach to Personalized Medicine
This talk discusses how one man used various omics technologies like genomics, metagenomics, metabolomics, and imaging to gain insights into his own health. Over a decade, he tracked over a billion data points about himself including his microbiome, genome, blood variables, and medical images. This led to the discovery that he had an inflammatory bowel disease. He then used multi-omics analyses and computing resources to study his condition and microbiome in detail over time. This is an example of a systems approach to personalized medicine.
This document summarizes a novel micro-emulsion technology called Phage Emulsion, Secretion, and Capture (ESCape) that can be used for the directed evolution of antibodies. The technology utilizes water-in-oil emulsions to compartmentalize individual phage clones displaying antibodies so that they can be queried against antigens individually. This allows for finer discrimination of binding kinetics compared to traditional phage display methods. The document demonstrates that the technology can distinguish antibodies with a 300-fold difference in binding affinity and can be used to select antibodies with improved thermal stability.
This document provides information on viral diagnosis methods. It discusses:
1. Direct examination methods like antigen detection, electron microscopy, and PCR to detect viruses.
2. Indirect examination using cell culture, eggs, or animals to isolate and identify viruses. Cytopathic effects and immunofluorescence are used to detect growth.
3. Serology methods like ELISA, complement fixation, and neutralization to detect antibodies produced in response to viral infection. Rising titers indicate acute infection while IgM indicates primary infection.
Titration and isolation of viruses using cell culturesShadia Omar
There are several methods to quantify and isolate viruses, isolation of viral pathogens in cell cultures. This approach is often slow and requires considerable technical expertise, however, it is still considered as the “gold standard” for the laboratory diagnosis of viral disease. In this presentation, I will describe one of these methods which is TCID50 (Tissue culture infective dose 50 )
This document discusses various techniques for diagnosing and studying viruses in a laboratory setting. It describes growing viruses in cell cultures and embryonated eggs, observing cytopathic effects, and quantifying viruses using plaque assays, particle counting, and hemagglutination assays. It also covers transforming infected cells to develop continuous cell lines and detecting viral proteins and antibodies using techniques like western blotting. The goal is to isolate, propagate, quantify, and identify viruses for research and clinical diagnosis.
This ppt file represents a simple overview on what is antibody validation & how to validate an antibody before performing any research.
Used references are also included.
Monoclonal antibodies are antibodies that are produced by a single clone of cells and have identical binding sites. This document discusses the production of monoclonal antibodies through hybridoma technology, where antibody-producing B cells are fused with myeloma cells. It also summarizes the various applications of monoclonal antibodies in diagnostics, imaging, therapy, and purification. Monoclonal antibodies can be specifically targeted to antigens on cancer cells, delivering toxic drugs directly to tumors while sparing normal cells. Their high specificity makes them useful research and medical tools.
Sensing metabolites for the monitoring of tissue engineered construct cellula...Antoine DEGOIX
This document describes a study that aimed to develop correlations between metabolic rates (oxygen uptake, glucose consumption, lactate production) and cellularity of tissue-engineered constructs comprised of rat mesenchymal stem cells seeded on scaffolds and cultured in a perfusion bioreactor. Metabolite measurements were taken intermittently using a fiber-optic probe or assays, and correlated with cellularity data obtained destructively via DNA quantification. The resulting high R2 value correlations provide proof-of-concept that metabolic data can determine scaffold cellularity non-destructively and in real-time.
A Systems Approachto Personalized MedicineLarry Smarr
A Systems Approach to Personalized Medicine
This talk discusses how one man used various omics technologies like genomics, metagenomics, metabolomics, and imaging to gain insights into his own health. Over a decade, he tracked over a billion data points about himself including his microbiome, genome, blood variables, and medical images. This led to the discovery that he had an inflammatory bowel disease. He then used multi-omics analyses and computing resources to study his condition and microbiome in detail over time. This is an example of a systems approach to personalized medicine.
This document summarizes a novel micro-emulsion technology called Phage Emulsion, Secretion, and Capture (ESCape) that can be used for the directed evolution of antibodies. The technology utilizes water-in-oil emulsions to compartmentalize individual phage clones displaying antibodies so that they can be queried against antigens individually. This allows for finer discrimination of binding kinetics compared to traditional phage display methods. The document demonstrates that the technology can distinguish antibodies with a 300-fold difference in binding affinity and can be used to select antibodies with improved thermal stability.
This document provides information on viral diagnosis methods. It discusses:
1. Direct examination methods like antigen detection, electron microscopy, and PCR to detect viruses.
2. Indirect examination using cell culture, eggs, or animals to isolate and identify viruses. Cytopathic effects and immunofluorescence are used to detect growth.
3. Serology methods like ELISA, complement fixation, and neutralization to detect antibodies produced in response to viral infection. Rising titers indicate acute infection while IgM indicates primary infection.
Titration and isolation of viruses using cell culturesShadia Omar
There are several methods to quantify and isolate viruses, isolation of viral pathogens in cell cultures. This approach is often slow and requires considerable technical expertise, however, it is still considered as the “gold standard” for the laboratory diagnosis of viral disease. In this presentation, I will describe one of these methods which is TCID50 (Tissue culture infective dose 50 )
This document discusses various techniques for diagnosing and studying viruses in a laboratory setting. It describes growing viruses in cell cultures and embryonated eggs, observing cytopathic effects, and quantifying viruses using plaque assays, particle counting, and hemagglutination assays. It also covers transforming infected cells to develop continuous cell lines and detecting viral proteins and antibodies using techniques like western blotting. The goal is to isolate, propagate, quantify, and identify viruses for research and clinical diagnosis.
This ppt file represents a simple overview on what is antibody validation & how to validate an antibody before performing any research.
Used references are also included.
This document provides guidelines for the development, production, characterization, and specifications of monoclonal antibodies and related products intended for human use. It covers quality requirements for monoclonal antibodies to be used as medicinal products, including guidelines for development of the monoclonal antibody, production considerations regarding platform manufacturing and viral safety, characterization of physicochemical, immunological and biological properties, and specifications. The document replaces previous guidelines on monoclonal antibodies and sets quality standards for marketing authorization of these products in Europe.
Week 7 methods to study viruses & cht 26 nervuos system(1)Rohmat Chr
This document discusses various methods for studying viruses, including diagnostics and detection. It describes analyzing samples to determine if a virus is present, what type of virus it is, and how many viruses are in the sample. It discusses using virus culture, serological tests like ELISA and immunofluorescence assays, and genetic methods like PCR and electron microscopy for detection and identification. Virus culture techniques like growing viruses in eggs, mice, or cell lines are also outlined. The document provides details on different diagnostic techniques and their advantages and limitations.
Cell Well Ltd. is a company that develops and supplies cell-based products for hepatitis research, including a new human hepatocyte-like cell line called 4bHHl that is susceptible to hepatitis B virus (HBV) infection and can be used as a tool to study the HBV lifecycle and screen antiviral drugs and vaccines.
Pegs Europe 2015 Protein & Antibody Engineering SummitNicole Proulx
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With three consecutive years of 35% growth in attendance, and another year of expanded program coverage, this year’s event will feature:
700 attendees
175 technical presentations
125 scientific posters
Dedicated networking opportunities
Exclusive exhibit & poster viewing hours
Interactive roundtable, breakout & panel discussions
4 Factors That Affect Research ReproducibilityCellero
Learn how to improve reproducibility in your lab by focusing on these key sources of variability. Insights, data, and tips from an immunology and inflammation research laboratory. https://astartebio.com/research/
Sanjay Kumar Hirasker has over 8 years of experience in research and development in synthetic biology, with a focus on basic research. He has expertise in yeast metabolic engineering, developing cell-based assays using mammalian cell lines, and recombinant protein expression in yeast, bacteria, and mammalian cells. Currently he works as a research associate at E.I. DuPont India Pvt. Ltd. on yeast metabolic engineering projects.
Genes and Tissue Culture Assignment Presentation (Group 3)Lim Ke Wen
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant. Discuss the potential of using three dimensional cell cultures for anti-cancer drug screening.
3D In Vitro Model for Drug Efficiency Testingjudoublen
This document discusses the potential advantages of using 3D in vitro models compared to traditional 2D models for drug testing. It notes that 3D cultures more closely mimic the in vivo microenvironment and cell morphology. This allows 3D cultures to better predict cellular responses to drugs and provide more accurate models of disease. The document outlines several applications of 3D cultures, such as studying tumor development, evaluating drug sensitivity, and developing organs-on-chips microfluidic devices that model human organ functions.
The void between preclinical testing and clinical trials of drugs reveals a crucial roadblock to efficient drug discovery. This plan defines an apporach to bioengineer structurally representative human tissues in vitro using the power of outstanding international academic collaborations.
collaboration
3D In Vitro Models for Drug Efficiency TestingTiffany Ho
3D cell cultures more accurately model the in vivo microenvironment compared to traditional 2D cultures. 3D cultures form cell aggregates or spheroids, mimic tumor development, and allow for more effective drug testing compared to flat monolayers. Emerging technologies like organ-on-chip microfluidic devices and 3D printing have the potential to further advance 3D cell culture models by replicating the functions of human organs and embedding living cells in scaffolds.
SMi Group's 3d Cell Culture 2019 conferenceDale Butler
This document provides information on the 3rd Annual Conference on 3D Cell Culture taking place on February 20-21, 2019 in London, UK.
The conference will feature presentations and panel discussions on developing 3D cell culture technologies and their applications in drug development and disease modeling. Speakers will discuss topics such as organ-on-chip technologies, 3D bioprinting, developing translationally relevant 3D models, and using organoids and 3D neuronal/retinal models for toxicity testing. A pre-conference workshop on February 19th will demonstrate a new technique for histological assessment of 3D spheroid arrays.
Organ-on-chips are microfluidic cell culture chips that mimic organ-level physiology and functions. They allow for complex cell-cell and cell-matrix interactions in a controlled environment. Various organ models have been developed including lungs, liver, kidney, and skin. In India, researchers are working on skin, retina, placenta and infection models. Organ-on-chips could serve as alternatives to animal testing and help develop personalized disease models and therapies.
Microbiology Discussion 1 While Gram staining and visualization .docxannandleola
Microbiology Discussion 1
While Gram staining and visualization under a light microscope can be powerful tools to guide a clinical microbiologist in the identification of bacteria, this process rarely, if ever, is sufficient for making a definitive diagnosis of a disease caused by bacteria. On the other hand, electron microscopy is useful for not only assisting virologists in identifying disease-causing viral agents, but may perhaps provide definitive identification of these agents. Hazelton and Gelderblom (2003)1 have made the argument that electron microscopy should be the diagnostic tool of choice in many viral outbreaks because of the rapidity and fidelity of the result.
Do you agree with the statement above or not or not and why? Explain in detail and use the evidence to support your thought.
Discuss the importance of comparing multiple images of the same virus, perhaps from different patients believed to be infected with the same agent.
1Hazelton PR, Gelderblom HR. Electron microscopy for rapid diagnosis of emerging infectious agents.Emerg Infect Dis [serial online] 2003 Mar [date cited]. Available from: URL: http://www.cdc.gov/ncidod/EID/vol9no3/02-0327.htm
Reply back to classmates: Response has to be a paragraph.
1. Yes, i do agree with Hazelton and gelderblom that the electron microscopy should be the diagnostic tool of choice. I agree with this because after reading some articles i have found that the electron microscopy is fast and realiable. When you are trying to identify a disease or viral outbreak, you are going to need something that will give you fast results that you can trust. I also think when using the electron microscopy that you should use another tool to back your findings.
2. I agree with the statement, electron microscopy has two advantages over enzyme-linked immunosorbent assay and nucleic acid amplification tests. After a simple and fast negative stain preparation, the undirected, “open view” of electron microscopy allows rapid morphologic identification and differential diagnosis of different agents contained in the specimen. Details for efficient sample collection, preparation, and particle enrichment are given. Applications of diagnostic electron microscopy in clinically or epidemiologically critical situations as well as in bioterrorist events are discussed. Electron microscopy can be applied to many body samples and can also hasten routine cell culture diagnosis. To exploit the potential of diagnostic electron microscopy fully, it should be quality controlled, applied as a frontline method, and be coordinated and run in parallel with other diagnostic techniques. This just show that Gram staining is the first step identify a bacteria, when electron microscopy will make a more result to understand where and how the bacteria was produce. I feel that electron microscopy is just a more advance way to diagnosis the reasoning on how a bacteria was caused.
3. I agree with the statement above that the electron micros ...
This document discusses methods for clinical testing, specifically 3D cell culture and organ-on-chip technologies. It notes that animal testing is time-consuming, costly, and often does not predict human outcomes. Organ-on-chip technologies use microfabrication and microfluidics to create microenvironments that better simulate human physiology and organs. This allows for testing of drugs and toxins using human cells in a way that may replace animal models. Examples discussed include a lung-on-a-chip to study pulmonary edema and a proposed "body on a chip" with 3D printed miniature organs to improve drug development and reduce costs.
The document contains the answers to multiple choice and short answer questions regarding tissue engineering. It discusses three key components required for successful tissue engineering: implanted and cultured cells, biomaterial scaffolds, and biological signaling molecules. It also outlines growth factors involved in cell adhesion like PDGF, EGF, TGF-α, TGF-β, and IGF. Additionally, it states that current technology is not mature enough to develop adhesive tissues in the laboratory due to a need for more advanced techniques and an in-depth understanding of material ingredients and properties.
This document describes a microfluidic bioreactor system developed to provide controlled spatial and temporal concentration gradients of multiple molecular factors to 3D cultures of human pluripotent stem cells. The bioreactor contains rows of microwells connected by microchannels that generate stable concentration gradients when different factors are flowed through the lateral channels. Human embryonic and induced pluripotent stem cells were cultured as embryoid bodies in the bioreactor and exposed to gradients of mesoderm-inducing morphogens. Gene expression analysis showed the system could evaluate the initiation of mesodermal induction in a controlled manner. The bioreactor aims to provide a more in vivo-like model for studying stem cell development and differentiation.
The document summarizes a computational modeling approach for simulating synthetic microbial biofilms at a multiscale level. The approach combines 3D biophysical models of individual cells with models of genetic regulation and intercellular signaling. It was implemented in a software tool called CellModeller that uses parallel GPU computing to simulate over 30,000 cells in a typical biofilm colony within 30 minutes. Simulation results reproduced key features of experimentally observed E. coli biofilm colony morphologies. The modeling framework provides a way to predict the behavior of synthetic biofilms prior to experimental construction.
3D-Bioprinting coming of age-from cells to organsDaniel Thomas
Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially.
Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections of how a drug will react in a human patient.
A solution has emerged in the form of 3D-Bioprinting technology, developed for the scalable, accurate and repeatable deposition of biologically active materials. With advances in this biomanufacturing technology, durable biological tissues for use in testing new pharmaceutical products are now being harnessed and refined.
The potential of using 3D in vitro models for drug efficiency testing compare...Josiah Sim
Three key points:
1) 3D cell cultures provide a more physiologically relevant model than 2D cultures by mimicking the in vivo microenvironment and cell-cell interactions. However, 3D cultures are more complex and expensive.
2) Studies show 3D cultures better maintain tumor dormancy states and drug resistance patterns observed in patients. Ki-67 indexes indicate higher fractions of non-proliferating cells in 3D.
3) While 3D models are improving, they do not fully replicate the in vivo tumor microenvironment and are not yet standardized for high-throughput drug screening. Further development is still needed to address challenges like customizing the microenvironment and expanding models.
3 d biomatrix-white-paper-3d-cell-culture-101ratna azizah
This document provides an introduction to various 3D cell culture tools and techniques. It begins by explaining how 3D cell culture has evolved from being expensive and difficult to a wider array of options that better model the in vivo environment. Five main 3D culture methods are then described in detail: scaffold-free spheroid culture, scaffolds, gels, bioreactors, and microchips. Each method is explored in terms of materials, advantages, limitations, and example applications. Review articles are also cited for additional information on each technique.
Revolution of 3 d organ model in pharmacological researchsyeddastagir9
3D organ models have gained interest as alternatives to animal testing in pharmacological research. This seminar discusses the revolution of 3D organ models with a focus on 3D bioprinting approaches. It describes various 3D bioprinting methods like biomimicry and autonomous self-assembly used to create tissue structures. Examples of 3D bioprinted structures for organs like liver, kidney, heart and neural tissue are provided. The seminar highlights current research using 3D bioprinting for applications like vascularization, drug development, and high-throughput screening.
Development of cancer therapeutics is often carried out in 2D cultures prior to testing on animal models. 3D in vitro models better mimic the in vivo tumor microenvironment and cell-cell interactions compared to 2D cultures. A recent study tested the efficacy of cancer drugs on ovarian cancer cells cultured in a 3D model. The study found that two experimental drugs had stronger dose-dependent effects on cell viability compared to a market competitor drug when tested on cells in 3D culture.
This document provides guidelines for the development, production, characterization, and specifications of monoclonal antibodies and related products intended for human use. It covers quality requirements for monoclonal antibodies to be used as medicinal products, including guidelines for development of the monoclonal antibody, production considerations regarding platform manufacturing and viral safety, characterization of physicochemical, immunological and biological properties, and specifications. The document replaces previous guidelines on monoclonal antibodies and sets quality standards for marketing authorization of these products in Europe.
Week 7 methods to study viruses & cht 26 nervuos system(1)Rohmat Chr
This document discusses various methods for studying viruses, including diagnostics and detection. It describes analyzing samples to determine if a virus is present, what type of virus it is, and how many viruses are in the sample. It discusses using virus culture, serological tests like ELISA and immunofluorescence assays, and genetic methods like PCR and electron microscopy for detection and identification. Virus culture techniques like growing viruses in eggs, mice, or cell lines are also outlined. The document provides details on different diagnostic techniques and their advantages and limitations.
Cell Well Ltd. is a company that develops and supplies cell-based products for hepatitis research, including a new human hepatocyte-like cell line called 4bHHl that is susceptible to hepatitis B virus (HBV) infection and can be used as a tool to study the HBV lifecycle and screen antiviral drugs and vaccines.
Pegs Europe 2015 Protein & Antibody Engineering SummitNicole Proulx
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With three consecutive years of 35% growth in attendance, and another year of expanded program coverage, this year’s event will feature:
700 attendees
175 technical presentations
125 scientific posters
Dedicated networking opportunities
Exclusive exhibit & poster viewing hours
Interactive roundtable, breakout & panel discussions
4 Factors That Affect Research ReproducibilityCellero
Learn how to improve reproducibility in your lab by focusing on these key sources of variability. Insights, data, and tips from an immunology and inflammation research laboratory. https://astartebio.com/research/
Sanjay Kumar Hirasker has over 8 years of experience in research and development in synthetic biology, with a focus on basic research. He has expertise in yeast metabolic engineering, developing cell-based assays using mammalian cell lines, and recombinant protein expression in yeast, bacteria, and mammalian cells. Currently he works as a research associate at E.I. DuPont India Pvt. Ltd. on yeast metabolic engineering projects.
Genes and Tissue Culture Assignment Presentation (Group 3)Lim Ke Wen
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant. Discuss the potential of using three dimensional cell cultures for anti-cancer drug screening.
3D In Vitro Model for Drug Efficiency Testingjudoublen
This document discusses the potential advantages of using 3D in vitro models compared to traditional 2D models for drug testing. It notes that 3D cultures more closely mimic the in vivo microenvironment and cell morphology. This allows 3D cultures to better predict cellular responses to drugs and provide more accurate models of disease. The document outlines several applications of 3D cultures, such as studying tumor development, evaluating drug sensitivity, and developing organs-on-chips microfluidic devices that model human organ functions.
The void between preclinical testing and clinical trials of drugs reveals a crucial roadblock to efficient drug discovery. This plan defines an apporach to bioengineer structurally representative human tissues in vitro using the power of outstanding international academic collaborations.
collaboration
3D In Vitro Models for Drug Efficiency TestingTiffany Ho
3D cell cultures more accurately model the in vivo microenvironment compared to traditional 2D cultures. 3D cultures form cell aggregates or spheroids, mimic tumor development, and allow for more effective drug testing compared to flat monolayers. Emerging technologies like organ-on-chip microfluidic devices and 3D printing have the potential to further advance 3D cell culture models by replicating the functions of human organs and embedding living cells in scaffolds.
SMi Group's 3d Cell Culture 2019 conferenceDale Butler
This document provides information on the 3rd Annual Conference on 3D Cell Culture taking place on February 20-21, 2019 in London, UK.
The conference will feature presentations and panel discussions on developing 3D cell culture technologies and their applications in drug development and disease modeling. Speakers will discuss topics such as organ-on-chip technologies, 3D bioprinting, developing translationally relevant 3D models, and using organoids and 3D neuronal/retinal models for toxicity testing. A pre-conference workshop on February 19th will demonstrate a new technique for histological assessment of 3D spheroid arrays.
Organ-on-chips are microfluidic cell culture chips that mimic organ-level physiology and functions. They allow for complex cell-cell and cell-matrix interactions in a controlled environment. Various organ models have been developed including lungs, liver, kidney, and skin. In India, researchers are working on skin, retina, placenta and infection models. Organ-on-chips could serve as alternatives to animal testing and help develop personalized disease models and therapies.
Microbiology Discussion 1 While Gram staining and visualization .docxannandleola
Microbiology Discussion 1
While Gram staining and visualization under a light microscope can be powerful tools to guide a clinical microbiologist in the identification of bacteria, this process rarely, if ever, is sufficient for making a definitive diagnosis of a disease caused by bacteria. On the other hand, electron microscopy is useful for not only assisting virologists in identifying disease-causing viral agents, but may perhaps provide definitive identification of these agents. Hazelton and Gelderblom (2003)1 have made the argument that electron microscopy should be the diagnostic tool of choice in many viral outbreaks because of the rapidity and fidelity of the result.
Do you agree with the statement above or not or not and why? Explain in detail and use the evidence to support your thought.
Discuss the importance of comparing multiple images of the same virus, perhaps from different patients believed to be infected with the same agent.
1Hazelton PR, Gelderblom HR. Electron microscopy for rapid diagnosis of emerging infectious agents.Emerg Infect Dis [serial online] 2003 Mar [date cited]. Available from: URL: http://www.cdc.gov/ncidod/EID/vol9no3/02-0327.htm
Reply back to classmates: Response has to be a paragraph.
1. Yes, i do agree with Hazelton and gelderblom that the electron microscopy should be the diagnostic tool of choice. I agree with this because after reading some articles i have found that the electron microscopy is fast and realiable. When you are trying to identify a disease or viral outbreak, you are going to need something that will give you fast results that you can trust. I also think when using the electron microscopy that you should use another tool to back your findings.
2. I agree with the statement, electron microscopy has two advantages over enzyme-linked immunosorbent assay and nucleic acid amplification tests. After a simple and fast negative stain preparation, the undirected, “open view” of electron microscopy allows rapid morphologic identification and differential diagnosis of different agents contained in the specimen. Details for efficient sample collection, preparation, and particle enrichment are given. Applications of diagnostic electron microscopy in clinically or epidemiologically critical situations as well as in bioterrorist events are discussed. Electron microscopy can be applied to many body samples and can also hasten routine cell culture diagnosis. To exploit the potential of diagnostic electron microscopy fully, it should be quality controlled, applied as a frontline method, and be coordinated and run in parallel with other diagnostic techniques. This just show that Gram staining is the first step identify a bacteria, when electron microscopy will make a more result to understand where and how the bacteria was produce. I feel that electron microscopy is just a more advance way to diagnosis the reasoning on how a bacteria was caused.
3. I agree with the statement above that the electron micros ...
This document discusses methods for clinical testing, specifically 3D cell culture and organ-on-chip technologies. It notes that animal testing is time-consuming, costly, and often does not predict human outcomes. Organ-on-chip technologies use microfabrication and microfluidics to create microenvironments that better simulate human physiology and organs. This allows for testing of drugs and toxins using human cells in a way that may replace animal models. Examples discussed include a lung-on-a-chip to study pulmonary edema and a proposed "body on a chip" with 3D printed miniature organs to improve drug development and reduce costs.
The document contains the answers to multiple choice and short answer questions regarding tissue engineering. It discusses three key components required for successful tissue engineering: implanted and cultured cells, biomaterial scaffolds, and biological signaling molecules. It also outlines growth factors involved in cell adhesion like PDGF, EGF, TGF-α, TGF-β, and IGF. Additionally, it states that current technology is not mature enough to develop adhesive tissues in the laboratory due to a need for more advanced techniques and an in-depth understanding of material ingredients and properties.
This document describes a microfluidic bioreactor system developed to provide controlled spatial and temporal concentration gradients of multiple molecular factors to 3D cultures of human pluripotent stem cells. The bioreactor contains rows of microwells connected by microchannels that generate stable concentration gradients when different factors are flowed through the lateral channels. Human embryonic and induced pluripotent stem cells were cultured as embryoid bodies in the bioreactor and exposed to gradients of mesoderm-inducing morphogens. Gene expression analysis showed the system could evaluate the initiation of mesodermal induction in a controlled manner. The bioreactor aims to provide a more in vivo-like model for studying stem cell development and differentiation.
The document summarizes a computational modeling approach for simulating synthetic microbial biofilms at a multiscale level. The approach combines 3D biophysical models of individual cells with models of genetic regulation and intercellular signaling. It was implemented in a software tool called CellModeller that uses parallel GPU computing to simulate over 30,000 cells in a typical biofilm colony within 30 minutes. Simulation results reproduced key features of experimentally observed E. coli biofilm colony morphologies. The modeling framework provides a way to predict the behavior of synthetic biofilms prior to experimental construction.
3D-Bioprinting coming of age-from cells to organsDaniel Thomas
Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially.
Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections of how a drug will react in a human patient.
A solution has emerged in the form of 3D-Bioprinting technology, developed for the scalable, accurate and repeatable deposition of biologically active materials. With advances in this biomanufacturing technology, durable biological tissues for use in testing new pharmaceutical products are now being harnessed and refined.
The potential of using 3D in vitro models for drug efficiency testing compare...Josiah Sim
Three key points:
1) 3D cell cultures provide a more physiologically relevant model than 2D cultures by mimicking the in vivo microenvironment and cell-cell interactions. However, 3D cultures are more complex and expensive.
2) Studies show 3D cultures better maintain tumor dormancy states and drug resistance patterns observed in patients. Ki-67 indexes indicate higher fractions of non-proliferating cells in 3D.
3) While 3D models are improving, they do not fully replicate the in vivo tumor microenvironment and are not yet standardized for high-throughput drug screening. Further development is still needed to address challenges like customizing the microenvironment and expanding models.
3 d biomatrix-white-paper-3d-cell-culture-101ratna azizah
This document provides an introduction to various 3D cell culture tools and techniques. It begins by explaining how 3D cell culture has evolved from being expensive and difficult to a wider array of options that better model the in vivo environment. Five main 3D culture methods are then described in detail: scaffold-free spheroid culture, scaffolds, gels, bioreactors, and microchips. Each method is explored in terms of materials, advantages, limitations, and example applications. Review articles are also cited for additional information on each technique.
Revolution of 3 d organ model in pharmacological researchsyeddastagir9
3D organ models have gained interest as alternatives to animal testing in pharmacological research. This seminar discusses the revolution of 3D organ models with a focus on 3D bioprinting approaches. It describes various 3D bioprinting methods like biomimicry and autonomous self-assembly used to create tissue structures. Examples of 3D bioprinted structures for organs like liver, kidney, heart and neural tissue are provided. The seminar highlights current research using 3D bioprinting for applications like vascularization, drug development, and high-throughput screening.
Development of cancer therapeutics is often carried out in 2D cultures prior to testing on animal models. 3D in vitro models better mimic the in vivo tumor microenvironment and cell-cell interactions compared to 2D cultures. A recent study tested the efficacy of cancer drugs on ovarian cancer cells cultured in a 3D model. The study found that two experimental drugs had stronger dose-dependent effects on cell viability compared to a market competitor drug when tested on cells in 3D culture.
1. Three dimensional cell cultures are more clinically relevant for anti-cancer drug screening compared to traditional two dimensional cell cultures as they better mimic the tumor microenvironment.
2. In 3D cultures, cells can interact and organize in all three dimensions and form natural cell-cell attachments, barriers to drug diffusion, and gradients of soluble molecules similar to real tumors.
3. Studies show 3D cultures alter gene expression and protein production in cells to make them more resistant to drugs, providing more accurate predictions of drug responses than 2D cultures.
1. Three dimensional cell cultures are more clinically relevant for anti-cancer drug screening compared to traditional two dimensional cell cultures as they better mimic the in vivo tumor microenvironment.
2. In 3D cultures, cells can interact and organize in all three dimensions to form natural cell-cell attachments and cell-extracellular matrix interactions similar to real tumors.
3. 3D cultures have been shown to more accurately reproduce drug resistance mechanisms found in tumors and provide more predictive results for drug efficacy compared to 2D monolayer cultures.
1. Three dimensional cell cultures are more clinically relevant for anti-cancer drug screening compared to traditional two dimensional cell cultures as they better mimic the in vivo tumor microenvironment.
2. In 3D cultures, cells can interact and organize in all three dimensions to form natural cell-cell attachments and cell-extracellular matrix interactions similar to real tumors.
3. 3D cultures have been shown to more accurately reproduce drug resistance mechanisms found in tumors and provide more predictive results for drug efficacy compared to 2D monolayer cultures.
Genes and Tissue Culture Technology Assignment (G6)Rohini Krishnan
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant.
Similar to New 3d printed biofilm models for studying multispecies bacterial communities (20)
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
2. 2
INTRODUCTION
Unlike free-floating planktonic bacteria that are quite
resistant to antibiotics and antimicrobials (such as
chlorhexidine (CHG) and nano crystalline silver), biofilms
are polymicrobial bacterial communities that are more
resistant to mechanical shear, antibiotics, and
antimicrobials.
Biofilms consist of a close network of bacteria that are
tethered together with a slime-like matrix mostly
consisting of exopolysaccharides, proteins, and nucleic acids (referred to as the EPS). This
dense community of bacteria has multiple layers with the top layer shedding active
planktonic-like bacteria while the deeper layers are more senescent (no longer capable of
dividing but still alive, from Latin: senescere, meaning "to grow old”).
3D BIOFILM MODELS
The challenge with testing antimicrobials with planktonic bacteria is that most culture
models do not reflect the complex molecular determinants that mediate quorum
sensing, sporulation, and other adaptive phenotypes that are representative of a true
biofilm. Several labs have made great strides in creating biofilm models using
bioreactors and cartridge-like drip models. In our experience, these models fail to set up
robust biofilms that are as durable as those developed in vivo. Imagine just for a
moment the biofilms and plaque that build up on our teeth while sleeping overnight or
the biofilm that grows on your pet’s water dish in less than 24 hours when you forget to
change the dish. Another example is the biofilm in a chronic wound that is resistant to
most antibiotics and antimicrobials including bleach solution.
In 2013, Connell and colleagues at the University of Texas demonstrated that they could
use a 3D printer to study bacterial communities. We have used this approach at 3DL
with an experimental 3D printer to establish polymicrobial biofilms that are more robust
and reproducible that can be tested both in vitro and in vivo in a modified mouse model.
The 3D printed biofilm models are much more consistent in terms of the amount of
protein and bacteria dispensed that can provide for more uniform replicates that have
less standard deviation of error than those established from the other well-
characterized biofilm models described below.
KEY POINTS
Every biofilm model
has it pitfalls and
strengths.
Use at least two
models to validate
the efficacy of your
antimicrobial
therapy.
3DL can provide
robust biofilm
models to accelerate
your pre-clinical
development.
Figure 1 Atomic Force Microscopy (AFM):
This is an image of a bacterial biofilm of
Staphylococcus aureus, Pseudomonas
aeruginosa, and Streptococcus pyogenes
Figure 2 This 3D Printer is used in
printing complex bacterial
communities. A separate white paper
will be submitted to Wound Repair and
Regeneration demonstrating the
validity of the model. We use a
Makerbot 2x replicator configured
with a high precision (NE 1000) syringe
pump configured with a thermo-kinetic
heat clamp to form bacterial biofilms.
3. 3
CDC BIOREACTOR MODEL
The CDC bioreactor model is a well-established continuous flow model
for forming multi-colony biofilms that was developed by Donlan et al.,
(2004) in the CDC Biofilm Lab. This model is well suited for microscopy
because the coupon material can be punched out of the slides so that
several replicates can be obtained for each sample condition. A typical
reactor has multiple polypropylene coupon holders suspended from
the support lid. Liquid growth media/biocide/etc. is circulated through
the chamber, while the liquid is mixed by a magnetic stir bar to
generate mechanical shear. More recent studies indicate that
coupons made of polyetheretherketone (PEEK) material can set up
more durable bio-films (Williams et al., 2011).
STIRRED CELLS AND DRIP CELLS
Stirred and drip cells are other examples of continuous biofilm models that
were developed to account for the mechanical shear forces that drive the
formation of more stable biofilms developed at Montana State University,
(MSU, Bozeman, MT: Herigstad et al., 2001). The stirred cells have the
benefit of a well-established EPS matrix and biofilm while removing the
preponderance of planktonic bacteria. The Center for Biofilm Engineering
(CBE) at MSU continues to be one of the leading institutes in studying
biofilm models. CBE hosts a variety of symposia and workshops on
biofilms both for industry and academia alike.
SKIN EXPLANT MODELS
UV sterilized porcine skin was developed as a biofilm model by Greg Schultz’s lab demonstrating
that a saline rinse retained 109
bacteria but hydro debridement reduced the bio-burden to 104
CFU/g (Yang et al., 2013). The explant model has shown to be a useful model to set up biofilms
in under 7 days for P. aeruginosa but > 7 days for S. aureus. The porcine skin is a reasonable
surrogate for the mouse model described below given that the data is comparable to the mouse
model but less expensive. Critics of this porcine skin model
suggest that it does not reflect human skin and there is no
immune response. However, Schultz and colleagues have
demonstrated that this model can produce biofilms that
are quite robust and even resistant to treatment with high
concentrations of antimicrobials and even chlorine bleach.
Figure 3 CDC Type Bioreactor: This
continuous flow vessel has room for 6
channels that can be processed
simultaneously and can be used with a
plethora of material types, including
plastics, metals, and ceramics.
Figure 4 A stirred cell bioreactor
allows for the formation of robust
biofilms. This model system has
the ability to run multiple coupons
ille tempore. Other variations
include a rotating disk that uses
centrifugal shear forces to set up
robust biofilms.
Figure 5 Porcine skin is ideal for establishing host
pathogen binding studies, less variable than the in
vivid model.
4. 4
Biofilm Models
Figure 6 Contact Mitchell.sanders@cmc-co.net for pricing inquiries on Biofilm Models.
MOUSE MODELS
Mouse biofilm models allow researchers to study how
biofilms can stall wound healing in normal and diabetic
animals (Zao et al., 2010). However, if you are not
studying wound healing and only studying biofilm
formation, the in vitro models are probably more than
sufficient because they have less variability than the
mouse model system. Because of the inherent variability of
the mouse model it takes 9 mice per group to get statistical
significance. Many of our colleagues feel that this mouse
model is less favorable than the in vitro models because of this variability. Our hypothesis is
that 3D printed biofilms will make the mouse model more robust and more applicable by
reducing the variability and therefore the number of replicates required for this model. We plan
to present these new results at the next Symposium on Advanced Wound Care (SAWC) in the
Fall of 2015.
SUMMARY
There are several models to study biofilms. However, each model has its own pitfalls and strengths. We
recommend that researchers use more than one model to validate their testing protocol with the
antibacterial or antimicrobial combination product. When you think about which lab you should use for
biofilm studies, consider a lab that has at least 20+ years of experience in studying biofilms and
determine if they are capable of generating timely, statistically significant, and high publication quality
data.
Figure 7 The balb/c mouse is commonly used
in biofilm studies. This model is
far less expensive than the partial thickness
porcine infection model or the rabbit urinary
catheter model (not shown), but is more
variable.
Biofilm Models Multispecies Advantages Pitfalls Measurments
CDC Bioreacter ++ Moderate Throughput STD Model/Cumbersome CFU Plating
Rotary Disk ++ Measures Shear Force Cumbersome CFU Plating
Drip Module ++ Robust Biofilms Old Model/Cumbersome CFU Plating/Fl Confocal Microscopy
New 3D Bioprinting +++ Versatile for in vitro & in vivo models New System CFU Plating/Fl Confocal Microscopy
Porcine Skin + Direct interaction with host protiens No Host Response, oversimplified CFU Plating/Fl Confocal Microscopy
Mouse Chronic Infection ++ Closest to Chronic Wound Infection Higher error requires 9 replicates CFU Plating
5. 5
AUTHORS
Mitchell Sanders MS, PhD, is the Managing Director of the Drug and Device Discovery
Lab at CMC Consulting. Mitch has 30+ years of experience in studying bacterial biofilms
and chronic wound infections. With ECI Biotech, Mitchell has produced over 12 peer-
reviewed publications and 24 worldwide patents in medical device and in vitro
diagnostics. Mitchell is an expert in clinical and translational research and is a reviewer
for the Wound Healing Society, CIMIT, MassVentures, MIT, WPI, Tech Sandbox, Piranha
Pond, SBANE and the Venture Forum. Mitchell has an MS and PhD from WPI in
molecular biology and biomedical sciences with 2 Postdocs (biochemistry and pathogen
genetics) at the Whitehead Institute/MIT.
Lindsay Poland is a scientist at 3DL who has 10+ years of experience in studying clinical
microbiology and protein biochemistry. Lindsay is an expert in molecular biology and
protein biochemistry of chronic wounds. She has 14 years of experience with almost 11
of them being in the industry with Mitch Sanders at ECI Biotech (Worcester MA)
studying wound repair and regeneration and chronic wound infection.
6. 6
REFERENCES
1. Larkö E, Persson A, Blom K. Effect of superabsorbent dressings in a 3D cellular tissue model of
Pseudomonas aeruginosa biofilm.
2. J Wound Care. 2015 May; 24(5):204-10. doi: 10.12968/jowc.2015.24.5.204.
3. Chang CB, Walking JN, Kim SH, Shum HC, Waits DA. Monodisperse Emulsion Drop Microenvironments for
Bacterial Biofilm Growth. Small. 2015 May 8. doi: 10.1002/smll.201403125. [Epub ahead of print]
PMID:25959709
4. Billings N, Birjiniuk A, Samad TS, Doyle PS, Ribbeck K. Material properties of biofilms-a review of methods
for understanding permeability and mechanics. Rep Prog Phys. 2015 Feb;78(3):036601. doi:
10.1088/0034-4885/78/3/036601. Epub 2015 Feb 26. PMID: 25719969
5. Connell JL, Kim J, Shear JB, Bard AJ, Whiteley M. Real-time monitoring of quorum sensing in 3D-
printed bacterial aggregates using scanning electrochemical microscopy. Proc Natl Acad Sci U S A. 2014
Dec 23;111(51):18255-60. doi: 10.1073/pnas.1421211111. Epub 2014 Dec 8. PMID:25489085
6. Connell JL, Ritschdorff ET, Whiteley M, Shear JB. 3D printing of microscopic bacterial communities. Proc
Natl Acad Sci U S A. 2013 Nov 12;110(46):18380-5. doi: 10.1073/pnas.1309729110. Epub 2013 Oct 7.
7. Tran PL, Hamood AN, de Souza A, Schultz G, Liesenfeld B, Mehta D, Reid TW. A study on the ability of
quaternary ammonium groups attached to a polyurethane foam wound dressing to inhibit bacterial
attachment and biofilm formation. Wound Repair Regen. 2015 Jan;23(1):74-81. doi: 10.1111/wrr.12244.
Epub 2015 Feb 13. PMID: 25469865
8. Yang Q, Phillips PL, Sampson EM, Progulske-Fox A, Jin S, Antonelli P,Schultz GS. Development of a novel ex
vivo porcine skin explant model for the assessment of mature bacterial biofilms. Wound Repair Regen.
2013 Sep-Oct;21(5):704-14. doi: 10.1111/wrr.12074. Epub 2013 Aug 8. PMID: 23927831.
9. Williams DL1, Woodbury KL, Haymond BS, Parker AE, Bloebaum RD. A modified CDC biofilm reactor to
produce mature biofilms on the surface of peek membranes for an in vivo animal model application. Curr
Microbiol. 2011 Jun;62(6):1657-63. doi: 10.1007/s00284-011-9908-2. Epub 2011 Mar 25.
10. Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, et al.: Model system for growing and
quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol 2004,
70:4980-4988.
11. Zelver N, Hamilton M, Pitts B, Goeres D, Walker D, Sturman P, Heersink J. Measuring antimicrobial effects
on biofilm bacteria: From laboratory to field in R.J. Doyle, et al. (eds), Biofilms: Methods in Enzymology,
Academic Press, San Diego, CA, 1999, pp.608-628.
12. Herigstad B, Hamilton M, Heersink J. How to optimize the drop plate method for enumerating
bacteria. J Microbiol Meth, 2001; 44(2):121-129
13. Zhao G1, Hochwalt PC, Usui ML, Underwood RA, Singh PK, James GA, Stewart PS, Fleckman P, Olerud JE.
Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model
for the study of chronic wounds. Wound Repair Regen. 2010 Sep-Oct;18(5):467-77. doi: 10.1111/j.1524-
475X.2010.00608.x. Epub 2010 Aug 19.
7. 7
ABOUT CMC CONSULTING GROUP
The CMC Group is an international advisory firm providing integrated
transaction services, management and medical affairs consulting and
contract research to companies in the life science industries. This
integration provides clients a seamless interface between strategy and
implementation and incorporates a range of perspectives designed to
optimize engagement outcomes. With offices in the United States, Asia
and throughout the EU, the firm complements global industry knowledge
with rich local market insight.
LOCATIONS
Munich, Germany
Phone: +49 89 41614220
info@cmc-co.net
Boston, USA
Phone: +1 508 7209803
boston@cmc-co.net
Paris, France
Phone: +33 1 44549623
france@cmc-co.net
Amsterdam, Netherlands
Phone: +31 35 6940999
benelux@cmc-co.net
Milan, Italy
Phone: +39 0396260093
italy@cmc-co.net
Barcelona, Spain
Phone: +34 93 4067171
spain@cmc-co.net
Poznan, Poland
Phone: +48 61 66001509
polska@cmc-co.net
Penang, Malaysia
Phone: +60 4 2362566
asia-pacific@cmc-co.net
Shanghai, China
Phone: +86 21 61721632
asia-pacific@cmc-co.net
Your Global Partner for Growth in Healthcare
LEARN MORE
www.cmc-co.net